Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunometabolic reprogramming of <i>Mycobacterium tuberculosis</i>-responsive memory CD4<sup>+</sup> T cell subsets is linked to long-term protective immunity.

Frontiers in tuberculosis·2026
Same author

Development of a four-gene host signature for paucibacillary TB among symptomatic individuals with sputum Xpert MTB/RIF Ultra very low and trace results.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

From Exposure to Disease: Predicting Tuberculosis Progression.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

A Narrative Review of the Regional Prospective Observational Research in Tuberculosis International Consortium: Sharing Diverse Data and Specimens in the Fight Against Tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

PET-CT benchmarked detection and 5-year progression of asymptomatic tuberculosis: a longitudinal, prospective cohort study.

The Lancet. Respiratory medicine·2026
Same author

Acceptability and feasibility of oral swabs for tuberculosis diagnosis in young children: a qualitative study from Uganda and Peru.

Frontiers in tuberculosis·2026

Related Experiment Video

Updated: May 23, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Ten challenges for TB biomarkers.

Tom H M Ottenhoff1, Jerrold J Ellner, Stefan H E Kaufmann

  • 1Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, The Netherlands. t.h.m.ottenhoff@lumc.nl

Tuberculosis (Edinburgh, Scotland)
|March 24, 2012
PubMed
Summary

Identifying biomarkers of protection against tuberculosis (TB) is crucial for accelerating vaccine development. This study highlights ten major challenges and proposes solutions for TB biomarker discovery and validation.

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Related Experiment Videos

Last Updated: May 23, 2026

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Development of effective tuberculosis (TB) vaccines is hindered by the lack of validated biomarkers of protection.
  • Such biomarkers are essential for evaluating vaccine efficacy in clinical trials and guiding preclinical development.
  • Current understanding of TB pathogenesis presents significant roadblocks to biomarker identification.

Purpose of the Study:

  • To discuss major challenges in identifying and validating biomarkers of protection against TB.
  • To highlight current limitations in understanding TB pathogenesis relevant to biomarker discovery.
  • To propose new solutions and strategies for overcoming these challenges.

Main Methods:

  • Literature review and expert discussion on TB pathogenesis and biomarker development.
  • Analysis of current roadblocks in TB vaccine research.
  • Formulation of proposed solutions and strategies for biomarker validation.

Main Results:

  • Ten major challenges for TB biomarker identification and validation were identified.
  • Key limitations in understanding TB pathogenesis were highlighted.
  • New strategies and solutions for biomarker discovery were proposed.

Conclusions:

  • Validated biomarkers of protection are critical for advancing TB vaccine development.
  • Addressing the identified challenges and limitations is essential for successful biomarker discovery.
  • Proposed solutions offer a pathway towards more effective TB vaccines.